Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Jan;37(1):1-3.
doi: 10.1038/npp.2011.233.

Neurotherapeutics

Gwenn S Smith, Xiaohua Li, P Jeffrey Conn
Editorial

Neurotherapeutics

Gwenn S Smith et al. Neuropsychopharmacology. 2012 Jan.
No abstract available

PubMed Disclaimer

References

    1. Addolorato G, Leggio L, Hopf FW, Diana M, Bonci A.2012. Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation. Neuropsychopharmacology 37162–176. - PMC - PubMed
    1. Moghaddam B, Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 2012;37:4–15. - PMC - PubMed
    1. Day JJ, Sweatt JD. Epigenetic treatments for cognitive impairments. Neuropsychopharmacology. 2012;37:246–259. - PMC - PubMed
    1. Jones C, Byun, Bubser M. Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia. Neuropsychopharmacology. 2012;37:16–42. - PMC - PubMed
    1. Li X, Shelton R, Frye M. Review of pharmacologic treatment in mood disorders and future directions for drug development. Neuropsychopharmacology. 2012;37:76–100. - PMC - PubMed

Publication types